Elena De Cristofaro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Elena De Cristofaro has a total of 190 co-authors. Here are the top co-authors by number of shared publications:
Jérôme Rivory
Hospital Group Edouard Herriot, France
28 shared publications- Mathieu Pioche
Department of Gastroenterology and Endoscopy, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France
14 shared publications - Mathieu Pioche
Department of Gastroenterology and Endoscopy, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France
14 shared publications Alexandru Lupu
Hopital Edouard Herriot, Hospices Civils de Lyon, France
11 shared publicationsJérémie Jacques
Dupuytren Hospital, France
10 shared publications- Pierre Lafeuille
Endoscopy and Gastroenterology Unit, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France
10 shared publications
Latest Publications
- 22 October 2026
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 104 (5) , 914-915
Response:
- Open Access
- 9 October 2026
- Published by Elsevier in Digestive and Liver Disease
- Vol. 58 (12) , 1569-1574
Adherence to advanced therapies in inflammatory bowel diseases: Real-world rates and predictors of non-adherence
- 9 October 2026
- Published by Elsevier in Digestive and Liver Disease
- Vol. 58 (12) , 1569-1574
Open AccessAdherence to advanced therapies in inflammatory bowel diseases: Real-world rates and predictors of non-adherence
- 21 August 2026
- Published by Georg Thieme Verlag KG in Endoscopy
Risk of lymph node metastasis in T1 colorectal cancer with isolated deep submucosal invasion: a multicenter European study
Advances in colorectal cancer (CRC) screening and endoscopic techniques have led to increased detection of T1 CRC. Patient management relies on histopathological criteria predicting lymph node metastasis (LNM), including submucosal invasion depth (SID) >1000 µm. However, the independent prognostic value of isolated deep invasion remains unclear. We performed a retrospective multicenter study of patients treated at 18 European centers between 2009 and 2022. Patients with T1 CRC endoscopically resected en bloc and with isolated SID >1000 µm (without other high-risk features) were included. Two groups were analyzed: patients who underwent additional surgery and those who were followed with surveillance. Rates of LNM (surgery group) and recurrence (local and distant; surveillance group) were assessed. Exploratory multivariable analyses were performed to evaluate clinicopathological factors associated with LNM. Among 179 included patients (124 surgery, 55 surveillance), LNM was found in 16/124 surgical specimens (12.9%; 95%CI 7.7–20.4) and recurrence occurred in 2/55 patients undergoing surveillance (3.6%; 95%CI 0.4–12.6). LNM occurred in 1/50 patients (2.0%) with SID <2000 µm and in 15/74 patients (20.3%) with SID ≥2000 µm. Multivariable analysis revealed SID ≥2000 µm (odds ratio [OR] 3.59; 95%CI 1.14–13.71) and colonic (vs. rectal) tumor location (OR 3.63; 95%CI 1.07–16.77) as factors associated with LNM. Isolated deep submucosal invasion in T1 CRC was associated with a non-negligible rate of LNM in this real-world cohort. In exploratory analyses, SID ≥2000 µm was associated with LNM.
- 21 August 2026
- Published by Georg Thieme Verlag KG in Endoscopy
Risk of lymph node metastasis in T1 colorectal cancer with isolated deep submucosal invasion: a multicenter European study
Advances in colorectal cancer (CRC) screening and endoscopic techniques have led to increased detection of T1 CRC. Patient management relies on histopathological criteria predicting lymph node metastasis (LNM), including submucosal invasion depth (SID) >1000 µm. However, the independent prognostic value of isolated deep invasion remains unclear. We performed a retrospective multicenter study of patients treated at 18 European centers between 2009 and 2022. Patients with T1 CRC endoscopically resected en bloc and with isolated SID >1000 µm (without other high-risk features) were included. Two groups were analyzed: patients who underwent additional surgery and those who were followed with surveillance. Rates of LNM (surgery group) and recurrence (local and distant; surveillance group) were assessed. Exploratory multivariable analyses were performed to evaluate clinicopathological factors associated with LNM. Among 179 included patients (124 surgery, 55 surveillance), LNM was found in 16/124 surgical specimens (12.9%; 95%CI 7.7–20.4) and recurrence occurred in 2/55 patients undergoing surveillance (3.6%; 95%CI 0.4–12.6). LNM occurred in 1/50 patients (2.0%) with SID <2000 µm and in 15/74 patients (20.3%) with SID ≥2000 µm. Multivariable analysis revealed SID ≥2000 µm (odds ratio [OR] 3.59; 95%CI 1.14–13.71) and colonic (vs. rectal) tumor location (OR 3.63; 95%CI 1.07–16.77) as factors associated with LNM. Isolated deep submucosal invasion in T1 CRC was associated with a non-negligible rate of LNM in this real-world cohort. In exploratory analyses, SID ≥2000 µm was associated with LNM.
- Open Access
- 6 August 2026
- Published by Georg Thieme Verlag KG in Endoscopy International Open
Impact of teleconsultation before endoscopic submucosal dissection on quality of care and environmental sustainability: a French multicenter study
Introduction: The European Society of Gastrointestinal Endoscopy has highlighted the environmental impact of endoscopic practice and the need to reduce it. One of the major contributors is patient transportation, despite the availability of remote alternatives for pre-procedural consultations. The aim of this study was to compare face-to-face (FF) and virtual remote (VR) consultations prior to colorectal endoscopic submucosal dissection (ESD) in terms of effectiveness, safety, and carbon footprint. Methods: We used a prospective national database including consecutive colorectal ESD cases performed in France between July 2023 and September 2024. Pre-procedural consultations were conducted either FF or via VR consultation, according to patient preference and logistical feasibility. Procedure-related travel included diagnostic colonoscopy and/or local consultation, anesthesiology consultation (local or remote, excluding same-day combined visits), gastroenterology consultation at the referral center, and travel for the ESD procedure itself. Environmental impact was estimated based on the distance between the patient’s residence and the endoscopy unit, the mode of transportation, and validated conversion coefficients. Results: Between July 2023 and September 2024, 1,729 patients undergoing colorectal ESD were included; 1,451 (84%) underwent face-to-face (FF) and 278 (16%) virtual remote (VR) pre-procedural consultations. Baseline characteristics were comparable. En bloc, R0, and curative resection rates were similar between FF and VR groups (97% vs 95%, p=0.31; 92% vs 88%, p=0.13; 90% vs 90%, p=0.86), as were bleeding and perforation rates. The median cumulative travel distance was significantly lower in the VR group (180.0 km [IQR 261.0] vs 394.6 km [IQR 447.6], p<0.001). Median cumulative carbon footprint decreased from 89.4 to 31.9 CO₂-eq units (p<0.001), corresponding to a total saving of 51,106 CO₂-eq units. Conclusion: Colorectal ESD performed after VR consultation shows comparable effectiveness and safety to FF consultation, while significantly reducing the carbon footprint.
- 6 August 2026
- Published by Georg Thieme Verlag KG in Endoscopy International Open
Open AccessImpact of teleconsultation before endoscopic submucosal dissection on quality of care and environmental sustainability: a French multicenter study
Introduction: The European Society of Gastrointestinal Endoscopy has highlighted the environmental impact of endoscopic practice and the need to reduce it. One of the major contributors is patient transportation, despite the availability of remote alternatives for pre-procedural consultations. The aim of this study was to compare face-to-face (FF) and virtual remote (VR) consultations prior to colorectal endoscopic submucosal dissection (ESD) in terms of effectiveness, safety, and carbon footprint. Methods: We used a prospective national database including consecutive colorectal ESD cases performed in France between July 2023 and September 2024. Pre-procedural consultations were conducted either FF or via VR consultation, according to patient preference and logistical feasibility. Procedure-related travel included diagnostic colonoscopy and/or local consultation, anesthesiology consultation (local or remote, excluding same-day combined visits), gastroenterology consultation at the referral center, and travel for the ESD procedure itself. Environmental impact was estimated based on the distance between the patient’s residence and the endoscopy unit, the mode of transportation, and validated conversion coefficients. Results: Between July 2023 and September 2024, 1,729 patients undergoing colorectal ESD were included; 1,451 (84%) underwent face-to-face (FF) and 278 (16%) virtual remote (VR) pre-procedural consultations. Baseline characteristics were comparable. En bloc, R0, and curative resection rates were similar between FF and VR groups (97% vs 95%, p=0.31; 92% vs 88%, p=0.13; 90% vs 90%, p=0.86), as were bleeding and perforation rates. The median cumulative travel distance was significantly lower in the VR group (180.0 km [IQR 261.0] vs 394.6 km [IQR 447.6], p<0.001). Median cumulative carbon footprint decreased from 89.4 to 31.9 CO₂-eq units (p<0.001), corresponding to a total saving of 51,106 CO₂-eq units. Conclusion: Colorectal ESD performed after VR consultation shows comparable effectiveness and safety to FF consultation, while significantly reducing the carbon footprint.
- 10 March 2026
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 20 (3)
Dysplasia in inflammatory bowel disease pseudopolyps
Dear Editor, We thank Ketenci and colleagues for their interest in our work and for providing the opportunity to further clarify and contextualize our findings. In our view, the interpretation proposed by Ketenci and colleagues in their commentary to our work did not sufficiently consider the limitations explicitly acknowledged in our paper and did not fully reflect the implications of the data we presented. 1, 2 We therefore wish to address the points raised in their commentary in a structured manner. We fully acknowledge that our study population does not encompass the entire range of post-inflammatory polyps observed during inflammatory bowel disease (IBD) surveillance. As clearly stated in the Methods and Discussion sections of our paper, the analysis was deliberately restricted to pseudopolyps that were endoscopically removed. Accordingly, patients with extensive or carpet-like pseudopolyposis—where comprehensive mucosal evaluation is inherently difficult and complete resection is impractical—were excluded by design. This constitutes a recognized and explicitly stated selection criterion rather than a methodological shortcoming and precludes generalization of our findings to all post-inflammatory polyps.
- 10 March 2026
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 20 (3)
Dysplasia in inflammatory bowel disease pseudopolyps
Dear Editor, We thank Ketenci and colleagues for their interest in our work and for providing the opportunity to further clarify and contextualize our findings. In our view, the interpretation proposed by Ketenci and colleagues in their commentary to our work did not sufficiently consider the limitations explicitly acknowledged in our paper and did not fully reflect the implications of the data we presented. 1, 2 We therefore wish to address the points raised in their commentary in a structured manner. We fully acknowledge that our study population does not encompass the entire range of post-inflammatory polyps observed during inflammatory bowel disease (IBD) surveillance. As clearly stated in the Methods and Discussion sections of our paper, the analysis was deliberately restricted to pseudopolyps that were endoscopically removed. Accordingly, patients with extensive or carpet-like pseudopolyposis—where comprehensive mucosal evaluation is inherently difficult and complete resection is impractical—were excluded by design. This constitutes a recognized and explicitly stated selection criterion rather than a methodological shortcoming and precludes generalization of our findings to all post-inflammatory polyps.
- Open Access
- 6 March 2026
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 32 (5) , 938-944
Early Intestinal Ultrasound Assessment Predicts Therapy Response: An Easy Tool for Clinical Decision-Making
Background: Transmural healing (TH) has emerged as a therapeutic target in Crohn’s disease (CD), providing a more comprehensive indicator of deep remission than mucosal healing alone. Intestinal ultrasound (IUS) is a noninvasive method for assessing TH, but its prognostic value remains insufficiently defined. Objective: The aim of this prospective study was to evaluate whether early improvement in IUS parameters during biological therapy could predict TH at 12 months. Design: This is a prospective multicenter study enrolling CD patients initiating biological therapies. IUS and Doppler parameters were assessed at baseline, 3 months, and 12 months. Delta (Δ) represented the variation in ultrasound measurements between baseline and 3 months. TH was defined as normalization of bowel wall features and absence of hypervascularization. Results: A total of 142 CD patients were included. At 12 months, the TH rate was 19%, the IUS response rate was 44%. Patients achieving TH showed a significantly greater ΔBWT than nonresponders (P = .0004). On ROC analysis, a ΔBWT reduction of 1.25 mm predicted TH with 73% sensitivity and 61% specificity. IUS responders had a significantly greater ΔBWT than nonresponders (P < .0001), with the same threshold predicting response with 83% sensitivity and 57% specificity. Notably, the combination of ΔBWT and Limberg score improvement was strongly associated with both TH (OR 13.26; P < .0001) and IUS response (OR 20.9; P < .0001) at 12 months. Conclusion: Early reduction in BWT, especially when combined with Limberg score, is a strong predictor of TH and IUS response at 12 months, supporting the use of early IUS monitoring in clinical practice.
- 6 March 2026
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 32 (5) , 938-944
Open AccessEarly Intestinal Ultrasound Assessment Predicts Therapy Response: An Easy Tool for Clinical Decision-Making
Background: Transmural healing (TH) has emerged as a therapeutic target in Crohn’s disease (CD), providing a more comprehensive indicator of deep remission than mucosal healing alone. Intestinal ultrasound (IUS) is a noninvasive method for assessing TH, but its prognostic value remains insufficiently defined. Objective: The aim of this prospective study was to evaluate whether early improvement in IUS parameters during biological therapy could predict TH at 12 months. Design: This is a prospective multicenter study enrolling CD patients initiating biological therapies. IUS and Doppler parameters were assessed at baseline, 3 months, and 12 months. Delta (Δ) represented the variation in ultrasound measurements between baseline and 3 months. TH was defined as normalization of bowel wall features and absence of hypervascularization. Results: A total of 142 CD patients were included. At 12 months, the TH rate was 19%, the IUS response rate was 44%. Patients achieving TH showed a significantly greater ΔBWT than nonresponders (P = .0004). On ROC analysis, a ΔBWT reduction of 1.25 mm predicted TH with 73% sensitivity and 61% specificity. IUS responders had a significantly greater ΔBWT than nonresponders (P < .0001), with the same threshold predicting response with 83% sensitivity and 57% specificity. Notably, the combination of ΔBWT and Limberg score improvement was strongly associated with both TH (OR 13.26; P < .0001) and IUS response (OR 20.9; P < .0001) at 12 months. Conclusion: Early reduction in BWT, especially when combined with Limberg score, is a strong predictor of TH and IUS response at 12 months, supporting the use of early IUS monitoring in clinical practice.
- Open Access
- 20 February 2026
- Published by Elsevier in Digestive and Liver Disease
- Vol. 58 (5) , 638-643
Development and validation of the IBD frailty score in a multicenter prospective cohort of IBD outpatients
- 20 February 2026
- Published by Elsevier in Digestive and Liver Disease
- Vol. 58 (5) , 638-643
Open AccessDevelopment and validation of the IBD frailty score in a multicenter prospective cohort of IBD outpatients
- Top Cited PapersOpen Access
- 17 February 2026
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 104 (3) , 436-444.e2
Lyon endoscopic submucosal dissection score: a preprocedure prediction model for operating time in colorectal endoscopic submucosal dissection
- 17 February 2026
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 104 (3) , 436-444.e2
Top Cited PapersOpen AccessLyon endoscopic submucosal dissection score: a preprocedure prediction model for operating time in colorectal endoscopic submucosal dissection
- Open Access
- 13 January 2026
- Published by Georg Thieme Verlag KG in Endoscopy International Open
- Vol. 14 (CP)
Post-inflammatory polyps and risk of dysplasia in inflammatory bowel disease: Wolves in sheep’s clothing?
Patients with longstanding and extensive inflammatory bowel disease (IBD) have an enhanced risk of colorectal cancer (CRC), which accounts for up to 10% of all IBD-related deaths. Chronicity of bowel inflammation, co-existence of primary sclerosing cholangitis, and a family history of sporadic colorectal cancer represent further risk factors for development of CRC. Colon post-inflammatory polyps are believed to be another risk factor for IBD-associated CRC, even though it remains unclear how presence of such lesions could influence CRC development.Although earlier observational studies suggested an association between post-inflammatory polyps and colorectal neoplasia, more recent studies have indicated that these lesions do not independently increase neoplasia risk. However, they may, nonetheless, complicate surveillance by obscuring dysplastic lesions, particularly when numerous, and they are best regarded as markers of chronic and recurrent mucosal inflammation. Moreover, emerging evidence suggests that a minority of post-inflammatory-like lesions may conceal or coexist with dysplasia, underscoring the diagnostic challenge posed by polypoid lesions in chronically inflamed mucosa. In this article, we review the available data about the association between post-inflammatory polyps and development of CRC in IBD and discuss how advances in technology, particularly development of artificial intelligence models integrated with endoscopy, may contribute to their appropriate management.
- 13 January 2026
- Published by Georg Thieme Verlag KG in Endoscopy International Open
- Vol. 14 (CP)
Open AccessPost-inflammatory polyps and risk of dysplasia in inflammatory bowel disease: Wolves in sheep’s clothing?
Patients with longstanding and extensive inflammatory bowel disease (IBD) have an enhanced risk of colorectal cancer (CRC), which accounts for up to 10% of all IBD-related deaths. Chronicity of bowel inflammation, co-existence of primary sclerosing cholangitis, and a family history of sporadic colorectal cancer represent further risk factors for development of CRC. Colon post-inflammatory polyps are believed to be another risk factor for IBD-associated CRC, even though it remains unclear how presence of such lesions could influence CRC development.Although earlier observational studies suggested an association between post-inflammatory polyps and colorectal neoplasia, more recent studies have indicated that these lesions do not independently increase neoplasia risk. However, they may, nonetheless, complicate surveillance by obscuring dysplastic lesions, particularly when numerous, and they are best regarded as markers of chronic and recurrent mucosal inflammation. Moreover, emerging evidence suggests that a minority of post-inflammatory-like lesions may conceal or coexist with dysplasia, underscoring the diagnostic challenge posed by polypoid lesions in chronically inflamed mucosa. In this article, we review the available data about the association between post-inflammatory polyps and development of CRC in IBD and discuss how advances in technology, particularly development of artificial intelligence models integrated with endoscopy, may contribute to their appropriate management.